Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · IEX Real-Time Price · USD
3.947
+0.277 (7.54%)
At close: Apr 22, 2024, 4:00 PM
3.870
-0.077 (-1.94%)
After-hours: Apr 22, 2024, 4:22 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $71.90 million as of April 23, 2024. Its market cap has decreased by -37.37% in one year.
Market Cap
71.90M
Enterprise Value
51.91M
1-Year Change
-37.37%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $71.90M, a decrease of -65.56%. That is a compound annual growth rate of -36.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 71.10M | -0.28% |
Apr 18, 2024 | 71.30M | 30.35% |
Apr 17, 2024 | 54.70M | -12.48% |
Apr 16, 2024 | 62.50M | -0.32% |
Apr 15, 2024 | 62.70M | -0.63% |
Apr 12, 2024 | 63.10M | -0.16% |
Apr 11, 2024 | 63.20M | 1.61% |
Apr 10, 2024 | 62.20M | 2.81% |
Apr 9, 2024 | 60.50M | 0.67% |
Apr 8, 2024 | 60.10M | 0.50% |
Apr 5, 2024 | 59.80M | -0.83% |
Apr 4, 2024 | 60.30M | 0.17% |
Apr 3, 2024 | 60.20M | -0.99% |
Apr 2, 2024 | 60.80M | -7.60% |
Apr 1, 2024 | 65.80M | 3.13% |
Mar 28, 2024 | 63.80M | -4.35% |
Mar 27, 2024 | 66.70M | -3.61% |
Mar 26, 2024 | 69.20M | -3.35% |
Mar 25, 2024 | 71.60M | -1.78% |
Mar 22, 2024 | 72.90M | - |
Mar 21, 2024 | 72.90M | -2.41% |
Mar 20, 2024 | 74.70M | - |
Mar 19, 2024 | 74.70M | -0.27% |
Mar 18, 2024 | 74.90M | 5.49% |
Mar 15, 2024 | 71.00M | -2.61% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anebulo Pharmaceuticals | 72.09M |
Cognition Therapeutics | 71.76M |
Leap Therapeutics | 71.69M |
LAVA Therapeutics | 71.24M |
Monogram Orthopaedics | 71.18M |
Passage Bio | 70.85M |
HOOKIPA Pharma | 70.77M |
Entera Bio | 70.61M |